Molecular Identity
Tacedinaline
4-acetamido-N-(2-aminophenyl)benzamide
PubChem CID: 2746
Tacedinaline is a benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers. It has a role as an antineoplastic agent and an EC 3.5.1.98 (histone deacetylase) inhibitor. It is a member of acetamides, a member of benzamides and a substituted aniline. It is functionally related to a 1,2-phenylenediamine.
2D Structure
Properties
C15H15N3O2
Molecular Formula
269.30
Molecular Weight
g/mol
269.1164
Exact Mass
Da
1.3
XLogP
Drug-like (Lipinski: < 5)
84.2
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
3
H-Bond Acceptors
351
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Tacedinaline112522-64-2ci-9944-acetamido-N-(2-aminophenyl)benzamideCI 994TacedinalinaN-acetyldinalineGoe 5549Goe-55494-(Acetylamino)-N-(2-aminophenyl)benzamidePD-123654PD 123654C.I. 994UMF554N5FGN-(2-aminophenyl)-4-acetamidobenzamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tacedinaline
Loading drug network...